Loading...
Jasper Therapeutics, Inc.
JSPRW•NASDAQ
Healthcare
Biotechnology
$0.12
$0.00(0.00%)
Jasper Therapeutics, Inc. (JSPRW) Financial Performance & Statements
Review Jasper Therapeutics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
-10.71%
↓ 10.71%
Net Income Growth
100.00%
↑ 100.00%
Operating Cash Flow Growth
-20.23%
↓ 20.23%
Operating Margin
-7067.21%
↓ 7067.21%
Gross Margin
24.53%
↑ 24.53%
Net Profit Margin
1169.34%
↑ 1169.34%
ROE
19.07%
↑ 19.07%
ROIC
-183.30%
↓ 183.30%
Jasper Therapeutics, Inc. (JSPRW) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Jasper Therapeutics, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.17M | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $587000.00 | $0.00 | $299000.00 | $288000.00 |
| Gross Profit | $587000.00 | $0.00 | -$299000.00 | -$288000.00 |
| Gross Profit Ratio | $0.50 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $19.77M | $14.46M | $11.30M | $10.30M |
| SG&A Expenses | $5.80M | $5.43M | $4.70M | $4.49M |
| Operating Expenses | $25.57M | $19.89M | $15.99M | $14.78M |
| Total Costs & Expenses | $26.16M | $19.89M | $15.99M | $15.07M |
| Interest Income | $938000.00 | $1.28M | $1.45M | $1.39M |
| Interest Expense | $5.06M | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | -$1.13M | $541000.00 | $299000.00 | $288000.00 |
| EBITDA | $45.87M | -$19.35M | -$15.69M | -$14.78M |
| EBITDA Ratio | $39.08 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$25.29M | -$19.89M | -$15.99M | -$15.07M |
| Operating Income Ratio | -$21.54 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $72.23M | $1.25M | $1.41M | $1.34M |
| Income Before Tax | $46.95M | -$18.64M | -$14.58M | -$13.73M |
| Income Before Tax Ratio | $39.99 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $54276.00 | $0.00 | -$299000.00 | $244724.00 |
| Net Income | $46.95M | -$18.64M | -$14.58M | -$13.73M |
| Net Income Ratio | $39.99 | $0.00 | $0.00 | $0.00 |
| EPS | $3.22 | -$1.24 | -$0.97 | -$1.03 |
| Diluted EPS | $3.22 | -$1.24 | -$0.97 | -$1.03 |
| Weighted Avg Shares Outstanding | $14.58B | $15.001B | $14.99B | $13.33B |
| Weighted Avg Shares Outstanding (Diluted) | $14.58B | $15.001B | $14.99B | $13.33B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan